0001415889-18-000047.txt : 20180112 0001415889-18-000047.hdr.sgml : 20180112 20180112165643 ACCESSION NUMBER: 0001415889-18-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180110 FILED AS OF DATE: 20180112 DATE AS OF CHANGE: 20180112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jaksch Frank L Jr CENTRAL INDEX KEY: 0001437237 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37752 FILM NUMBER: 18526480 MAIL ADDRESS: STREET 1: 10005 MUIRLANDS BOULEVARD STREET 2: SUITE G FIRST FLOOR CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChromaDex Corp. CENTRAL INDEX KEY: 0001386570 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 262940963 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 10005 MUIRLANDS BLVD. STREET 2: STE. G, FIRST FLOOR CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: 949-419-0288 MAIL ADDRESS: STREET 1: 10005 MUIRLANDS BLVD. STREET 2: STE. G, FIRST FLOOR CITY: IRVINE STATE: CA ZIP: 92618 FORMER COMPANY: FORMER CONFORMED NAME: CODY RESOURCES, INC. DATE OF NAME CHANGE: 20070112 4 1 form4-01122018_010129.xml X0306 4 2018-01-10 0001386570 ChromaDex Corp. CDXC 0001437237 Jaksch Frank L Jr 10005 MUIRLANDS BLVD. SUITE G IRVINE CA 92618 true true false false CEO Common Stock 2018-01-10 4 M 0 22130 4.5 A 223687 D Common Stock 2018-01-10 4 S 0 22130 6.52 D 201557 D Common Stock 2018-01-11 4 M 0 6249 4.5 A 207806 D Common Stock 2018-01-11 4 S 0 6249 6.5 D 201557 D Common Stock 2075052 I By Black Sheep, FLP Employee Stock Options (right to buy) 4.50 2018-01-10 4 M 0 22130 0 D 2009-04-21 2018-04-21 Common Stock 22130 202804 D Employee Stock Options (right to buy) 4.50 2018-01-11 4 M 0 6249 0 D 2009-04-21 2018-04-21 Common Stock 6249 196555 D Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted on November 17, 2017. The options exercised and sold were scheduled to expire on April 21, 2018 and Mr. Jaksch sold the shares so that the proceeds can be used to cover the exercise payment and applicable withholding taxes due. The weighted average sale price for the transaction reported was $6.52, and the range of prices were between $6.50 and $6.58. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided. /s/ Frank Jaksch 2018-01-12